Study of monkeypox infection in Brazil
Part of Infections clinical trials.
This is an observational study that follows people with confirmed monkeypox (mpox) to better understand the illness over time. It may help doctors learn what to expect and improve care, but it does not test a new treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have confirmed mpox infection from a lab test (PCR, culture, or antigen test)
- The sample used for the test should be taken within about 4 days of starting the study
- Be able to give informed consent (agree to join after understanding the study)
- Be able to do follow-up in a decentralized way (follow-up that doesn’t require staying only in one place)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational study looks at how your body’s defenses work against mpox (monkeypox), based on blood and health information. You may be eligible if you recently got an mpox vaccine or have had mpox infection and are now out of isolation.
This study follows people with mpox and their close contacts in Guinea to learn how the virus spreads and to measure how well the mpox vaccine works. You would be involved for up to two months and help improve prevention and care.
This is an observational study that follows adults after they get a monkeypox vaccine to learn how their immune system responds. The results may help researchers understand what types of protection the vaccine creates.
This study follows people after confirmed mpox, after smallpox vaccination, or in people taking HIV PrEP to learn how the immune system responds over time. It may help scientists better understand protection and immune changes after these exposures.
This study looks at how well the mpox vaccine works during outbreaks. It tracks people who may have been exposed, those who have been vaccinated or already had mpox, and healthy volunteers.
This trial tests a new monkeypox vaccine to see if it is safe and helps the body build protection. It may be an option for adults who were born before 1980 and received a smallpox vaccine, or who meet other health criteria.
Hear when a new Monkeypox trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.